Lung Cancer and COVID-19: impact of the pandemic on screening and diagnosis

Screening rates and diagnoses have declined during the COVID-19 pandemic. This is concerning since the early detection of lung cancer may help lead to better overall survival outcomes. Lung Cancer and COVID-19 search: lung cancer, oncology, COVID-19, pandemic, screen, Merck
This content is only available to members. Learn more about membership here or login.